Track 20 Biotech Hedge Funds for $29/mo
The price of a nice dinner, for an analyst who never sleeps.
Know what top funds are buying, which catalysts are next, and what insiders are doing with their own money — before the market does.
Position changes from 20 specialist biotech hedge funds
Spot when 3+ funds independently buy the same stock
PDUFA dates, Phase 2/3 readouts, AdCom meetings
Dilution risk alerts before the offering drops
High SI + fund buying + catalyst = squeeze setup
Email alerts when funds touch your tickers
30-day money-back guarantee
Not satisfied? Full refund, no questions asked. Email us and we'll refund your payment immediately.
“Saved me hours every week. I used to manually check EDGAR for 13F filings — now I just read the digest.”
“The convergence signals are the real edge. Knowing when multiple funds pile into the same name is incredibly valuable.”
“Finally, a tool that tells me what the filing means — not just that it exists.”
Not ready? Get the free Monday digest first.
Frequently asked questions
Do I need a credit card for the free trial?
Yes. We require a card to start your trial, but you won't be charged for 14 days. Cancel from your dashboard anytime before then and you'll never see a charge.
What happens after the trial ends?
You'll be prompted to subscribe at $29/month to keep full access. If you don't subscribe, you can still receive the free Monday brief with top-line signals.
Can I cancel anytime?
Yes. Cancel from your dashboard at any time. No contracts, no commitments. Your access continues through the end of your billing period.
Where does the data come from?
All data is sourced directly from SEC EDGAR filings (13F, Form 4, 13D/13G), ClinicalTrials.gov for catalyst events, and FDA calendar dates. We parse and normalize the raw filings automatically.
How is this different from BPIQ or WhaleWisdom?
They're databases. We're the analyst who reads the database and writes you a brief. WhaleWisdom shows you that a fund holds a stock. We tell you how much, whether they're adding or trimming, what catalyst is coming, and what their insider is doing with their own money.
How accurate is the AI context?
The AI context is generated from structured data — SEC filings, clinical trial records, and financial metrics. It summarizes what the data shows, not predictions. Think of it as having an analyst read every filing for you and write a 2-sentence brief.